Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 3
1999 2
2000 2
2001 1
2002 2
2003 1
2004 3
2005 1
2006 1
2007 2
2008 1
2009 6
2010 9
2011 6
2012 8
2013 11
2014 5
2015 7
2016 2
2017 2
2018 7
2019 2
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

77 results
Results by year
Filters applied: . Clear all
Page 1
Galectin-3 and cancer stemness.
Nangia-Makker P, Hogan V, Raz A. Nangia-Makker P, et al. Glycobiology. 2018 Apr 1;28(4):172-181. doi: 10.1093/glycob/cwy001. Glycobiology. 2018. PMID: 29315388 Free PMC article. Review.
This structural complexity permits galectin-3 to associate with numerous molecules utilizing protein-protein and/or protein-carbohydrate interactions in the extra-cellular as well as intracellular milieu and regulate diverse signaling pathways, a number of which app …
This structural complexity permits galectin-3 to associate with numerous molecules utilizing protein-protein and/or protein-ca …
Overexpression of the galectin-3 during tumor progression in prostate cancer and its clinical implications.
Gao J, Li T, Mo Z, Hu Y, Yi Q, He R, Zhu X, Zhou X, She S, Chen Y. Gao J, et al. Int J Clin Exp Pathol. 2018 Feb 1;11(2):839-846. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31938173 Free PMC article.
Galectin-3 (gal-3) is a carbohydrate-binding protein involved in cancer progression and metastasis, including prostate tissues. ...In summary, our findings suggested the cleaved gal-3 could be a valuable diagnostic biomarker and a therape
Galectin-3 (gal-3) is a carbohydrate-binding protein involved in cancer progression and metastasis, including
Positive associations between galectin-3 and PSA levels in prostate cancer patients: a prospective clinical study-I.
Nakajima K, Heilbrun LK, Hogan V, Smith D, Heath E, Raz A. Nakajima K, et al. Oncotarget. 2016 Dec 13;7(50):82266-82272. doi: 10.18632/oncotarget.12619. Oncotarget. 2016. PMID: 27741512 Free PMC article.
Galectin-3 (Gal-3), an oncogenic pro-inflammatory protein, has been suggested as a possible complementary diagnostic candidate to prostate specific antigen (PSA) blood test for prostate cancer patients. ...Here, we report the associations
Galectin-3 (Gal-3), an oncogenic pro-inflammatory protein, has been suggested as a possible complementary diagnostic ca
Galectin-3 and cancer (Review).
Califice S, Castronovo V, Van Den Brûle F. Califice S, et al. Int J Oncol. 2004 Oct;25(4):983-92. Int J Oncol. 2004. PMID: 15375548 Review.
Its carbohydrate-binding properties constitute the basis for cell-cell and cell-matrix interactions and cancer progression. Modulation of galectin-3 expression in cancer cells has indeed been reported. These observations lead to the recognition of g
Its carbohydrate-binding properties constitute the basis for cell-cell and cell-matrix interactions and cancer progression. Modulatio …
Galectin-3 Is Implicated in Tumor Progression and Resistance to Anti-androgen Drug Through Regulation of Androgen Receptor Signaling in Prostate Cancer.
Dondoo TO, Fukumori T, Daizumoto K, Fukawa T, Kohzuki M, Kowada M, Kusuhara Y, Mori H, Nakatsuji H, Takahashi M, Kanayama HO. Dondoo TO, et al. Anticancer Res. 2017 Jan;37(1):125-134. doi: 10.21873/anticanres.11297. Anticancer Res. 2017. PMID: 28011482
Galectin-3 has been shown to be correlated with tumor progression in a variety of cancer types through the regulation of tumor proliferation, angiogenesis, and apoptosis. ...CONCLUSION: These results suggest that galectin-3 is a potential target
Galectin-3 has been shown to be correlated with tumor progression in a variety of cancer types through the regulation o
Galectin-3 Expression Correlates with Post-surgical Survival in Canine Oral Melanomas.
Vargas THM, Pulz LH, Ferro DG, Sobral RA, Venturini MAFA, Corrêa HL, Strefezzi RF. Vargas THM, et al. J Comp Pathol. 2019 Nov;173:49-57. doi: 10.1016/j.jcpa.2019.10.003. Epub 2019 Nov 13. J Comp Pathol. 2019. PMID: 31812173
Malignant melanomas (MMs) represent 7% of all malignant neoplasms in dogs. Oral melanocytic neoplasms are often malignant and associated with poor prognosis. ...Galectin (Gal)-3 is a prognostic marker for human neoplasms such as thyroid, gastric …
Malignant melanomas (MMs) represent 7% of all malignant neoplasms in dogs. Oral melanocytic neoplasms are often malignant and …
Regulation of prostate cancer progression by galectin-3.
Wang Y, Nangia-Makker P, Tait L, Balan V, Hogan V, Pienta KJ, Raz A. Wang Y, et al. Am J Pathol. 2009 Apr;174(4):1515-23. doi: 10.2353/ajpath.2009.080816. Epub 2009 Mar 12. Am J Pathol. 2009. PMID: 19286570 Free PMC article.
The present study was undertaken to understand the role of galectin-3 in the progression of prostate cancer. Immunohistochemical analysis of galectin-3 expression revealed that galectin-3 was cleaved during the progression o …
The present study was undertaken to understand the role of galectin-3 in the progression of prostate cancer. Imm …
The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment.
Farhad M, Rolig AS, Redmond WL. Farhad M, et al. Oncoimmunology. 2018 Feb 20;7(6):e1434467. doi: 10.1080/2162402X.2018.1434467. eCollection 2018. Oncoimmunology. 2018. PMID: 29872573 Free PMC article. Review.
Galectin-3 (Gal-3) is a lectin that contributes to TME immunosuppression and regulates diverse functions including cellular homeostasis and cancer biology. ...Here, we discuss the mechanisms by which Gal-3 regulates lymphocytes, the role of Gal-
Galectin-3 (Gal-3) is a lectin that contributes to TME immunosuppression and regulates diverse functions including cell
Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis.
Caputo S, Grioni M, Brambillasca CS, Monno A, Brevi A, Freschi M, Piras IS, Elia AR, Pieri V, Baccega T, Lombardo A, Galli R, Briganti A, Doglioni C, Jachetti E, Bellone M. Caputo S, et al. Front Immunol. 2020 Sep 10;11:1820. doi: 10.3389/fimmu.2020.01820. eCollection 2020. Front Immunol. 2020. PMID: 33013832 Free PMC article.
Galectin-3 (Gal-3) is an extracellular matrix glycan-binding protein with several immunosuppressive and pro-tumor functions. The role of Galectin-3 in cancer stem-like cells (CSCs) is poorly investigated. Here, we show that prostate
Galectin-3 (Gal-3) is an extracellular matrix glycan-binding protein with several immunosuppressive and pro-tumor funct
Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis.
Nakajima K, Kho DH, Yanagawa T, Harazono Y, Hogan V, Chen W, Ali-Fehmi R, Mehra R, Raz A. Nakajima K, et al. Cancer Res. 2016 Mar 15;76(6):1391-402. doi: 10.1158/0008-5472.CAN-15-1793. Epub 2016 Feb 2. Cancer Res. 2016. PMID: 26837763 Free PMC article.
Galectin-3 (Gal-3) has been implicated as a secreted factor that alters the bone microenvironment. Proteolytic cleavage of Gal-3 may also contribute to malignant cellular behaviors, but has not been addressed in cancer metastasis. ...During oste
Galectin-3 (Gal-3) has been implicated as a secreted factor that alters the bone microenvironment. Proteolytic cleavage
77 results
Jump to page
Feedback